AU2012281078B2 - Identifying affinity-matured human antibodies - Google Patents

Identifying affinity-matured human antibodies Download PDF

Info

Publication number
AU2012281078B2
AU2012281078B2 AU2012281078A AU2012281078A AU2012281078B2 AU 2012281078 B2 AU2012281078 B2 AU 2012281078B2 AU 2012281078 A AU2012281078 A AU 2012281078A AU 2012281078 A AU2012281078 A AU 2012281078A AU 2012281078 B2 AU2012281078 B2 AU 2012281078B2
Authority
AU
Australia
Prior art keywords
seq
primers
pcr
region
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012281078A
Other languages
English (en)
Other versions
AU2012281078A1 (en
Inventor
John Simard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xbiotech Inc
Original Assignee
Xbiotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xbiotech Inc filed Critical Xbiotech Inc
Publication of AU2012281078A1 publication Critical patent/AU2012281078A1/en
Application granted granted Critical
Publication of AU2012281078B2 publication Critical patent/AU2012281078B2/en
Priority to AU2017210585A priority Critical patent/AU2017210585B2/en
Assigned to XBIOTECH INC. reassignment XBIOTECH INC. Request to Amend Deed and Register Assignors: XBIOTECH, INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51Complete heavy chain or Fd fragment, i.e. VH + CH1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515Complete light chain, i.e. VL + CL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2012281078A 2011-07-12 2012-07-12 Identifying affinity-matured human antibodies Active AU2012281078B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2017210585A AU2017210585B2 (en) 2011-07-12 2017-08-03 Identifying affinity-matured human antibodies

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161506749P 2011-07-12 2011-07-12
US61/506,749 2011-07-12
PCT/US2012/046431 WO2013009967A2 (en) 2011-07-12 2012-07-12 Identifying affinity-matured human antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017210585A Division AU2017210585B2 (en) 2011-07-12 2017-08-03 Identifying affinity-matured human antibodies

Publications (2)

Publication Number Publication Date
AU2012281078A1 AU2012281078A1 (en) 2014-01-23
AU2012281078B2 true AU2012281078B2 (en) 2017-05-04

Family

ID=47506915

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2012281078A Active AU2012281078B2 (en) 2011-07-12 2012-07-12 Identifying affinity-matured human antibodies
AU2017210585A Active AU2017210585B2 (en) 2011-07-12 2017-08-03 Identifying affinity-matured human antibodies

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2017210585A Active AU2017210585B2 (en) 2011-07-12 2017-08-03 Identifying affinity-matured human antibodies

Country Status (11)

Country Link
US (6) US9234030B2 (https=)
EP (2) EP2731965A4 (https=)
JP (1) JP6731702B2 (https=)
KR (1) KR102139388B1 (https=)
CN (2) CN107090459A (https=)
AU (2) AU2012281078B2 (https=)
CA (1) CA2841475C (https=)
IL (2) IL230358B (https=)
MX (2) MX361600B (https=)
RU (2) RU2762685C2 (https=)
WO (1) WO2013009967A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6731702B2 (ja) * 2011-07-12 2020-07-29 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 親和性成熟化ヒト抗体の同定
US10119134B2 (en) 2013-03-15 2018-11-06 Abvitro Llc Single cell bar-coding for antibody discovery
GB201316644D0 (en) * 2013-09-19 2013-11-06 Kymab Ltd Expression vector production & High-Throughput cell screening
WO2015182749A1 (ja) * 2014-05-30 2015-12-03 国立大学法人富山大学 TCR cDNAの増幅方法
KR101753553B1 (ko) 2014-06-03 2017-07-03 엑스바이오테크, 인크. 스타필로코커스 아우레우스 감염의 치료 및 예방을 위한 조성물 및 방법
ES2895750T3 (es) 2014-09-15 2022-02-22 Abvitro Llc Secuenciación de alto rendimiento de colecciones de nucleótidos
US10975146B2 (en) 2018-06-29 2021-04-13 Cedars-Sinai Medical Center Interleukin-1 inhibition for combination treatment of pancreatic cancer
US20200392578A1 (en) * 2019-06-14 2020-12-17 The Regents Of The University Of California Methods of sequencing antibody chains from hybridomas and kits for practicing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE284897T1 (de) * 2000-03-10 2005-01-15 Large Scale Biology Corp Selfantigen-impfstoffe zur behandlung von b-zell lymphomen und sonstigen krebsen
AU2002953381A0 (en) * 2002-12-18 2003-01-09 Diatech Pty Ltd In vivo affinity maturation scheme
BRPI0412217A (pt) * 2003-07-29 2006-08-22 Genentech Inc método de avaliação da eficácia de anticorpo, métodos de imunoterapia, método de detecção de anticorpos neutralizantes a anticorpo terapêutico e método de avaliação da eficácia de antagonista
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
PE20071101A1 (es) 2005-08-31 2007-12-21 Amgen Inc Polipeptidos y anticuerpos
JP5205597B2 (ja) * 2007-06-01 2013-06-05 静岡県 1細胞レベルでの抗体遺伝子の解析・同定方法
RU2011117213A (ru) * 2008-09-30 2012-11-10 Эббот Лэборетриз (Us) Улучшенные библиотеки антител
EP2398913B1 (en) 2009-02-20 2016-03-30 F. Hoffmann-La Roche AG Method for obtaining immunoglobulin encoding nucleic acid
JP6731702B2 (ja) * 2011-07-12 2020-07-29 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 親和性成熟化ヒト抗体の同定

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CAMPBELL M J et al: "Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire", MOLECULAR IMMUNOLOGY, Vol. 29, No. 2, 1 February 1992 (1992-02-01 ), pages 193-203 *
DUBROVSKAYA V V et al: , MOLECULAR BIOLOGY, Vol. 41, No. 1, 1 February2007 (2007-02-01), pages 157-167 *
GLANVILLE, J. et al, 'Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire' Proc. Natl. Acad. Soc. USA, December 1 2009, Vol. 106, No. 48, Pages 20216-20221. *
LARRICK J W et al: "Polymerase chain reaction using mixed primers: cloning of human monoclonal antibody variable region genes from single hybridoma cells", BIOTECHNOLOGY. Vol. 7, 1 September 1989 (1989-09-01 ), pages 934-938 *
LARRICK J W et al: BIOCHEMICAL AND BIOPHYSICAL RESEARCH, Vol. 160, No. 3, 15 May1989 (1989-05-15), pages 1250-1256 *
PANSRI P et al "A compact phage display human scFv library for selection of antibodies to a wide variety of antigens", BMC BIOTECHNOLOGY, Vol. 9, No. 6, 29 January 2009 (2009-01-29), pages 1-16 *
SZANKASI P et al: "Clinical Laboratory Analysis of lmmunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis", JOURNAL OF MOLECULAR DIAGNOSTICS, Vol. 12, No. 2, March 2010 (2010-03), pages 244-249 *

Also Published As

Publication number Publication date
US9394536B2 (en) 2016-07-19
IL262977A (en) 2018-12-31
EP3034513A2 (en) 2016-06-22
KR20140044905A (ko) 2014-04-15
IL230358B (en) 2018-11-29
US9453217B2 (en) 2016-09-27
JP6731702B2 (ja) 2020-07-29
MX2014000431A (es) 2014-09-04
US20200071388A1 (en) 2020-03-05
KR102139388B1 (ko) 2020-07-30
EP2731965A2 (en) 2014-05-21
EP3034513A3 (en) 2016-08-10
US20130018173A1 (en) 2013-01-17
WO2013009967A2 (en) 2013-01-17
EP2731965A4 (en) 2015-06-03
JP2014521316A (ja) 2014-08-28
WO2013009967A3 (en) 2013-04-04
CN103687873B (zh) 2016-10-19
EP3034513B1 (en) 2020-09-02
AU2017210585B2 (en) 2019-07-25
CA2841475C (en) 2021-02-09
AU2012281078A1 (en) 2014-01-23
RU2017134418A3 (https=) 2021-06-10
US9670483B2 (en) 2017-06-06
US9234030B2 (en) 2016-01-12
MX2018015450A (es) 2021-11-16
RU2017134418A (ru) 2019-02-07
RU2014102617A (ru) 2015-08-20
CN103687873A (zh) 2014-03-26
US20160060618A1 (en) 2016-03-03
AU2017210585A1 (en) 2017-08-24
CN107090459A (zh) 2017-08-25
US20160060619A1 (en) 2016-03-03
MX361600B (es) 2018-12-11
CA2841475A1 (en) 2013-01-17
US20170233457A1 (en) 2017-08-17
IL262977B (en) 2020-07-30
RU2636045C2 (ru) 2017-11-17
RU2762685C2 (ru) 2021-12-22
US20160362679A1 (en) 2016-12-15

Similar Documents

Publication Publication Date Title
AU2017210585B2 (en) Identifying affinity-matured human antibodies
AU2019203048B2 (en) Express humanization of antibodies
JP6250284B2 (ja) ヒト化抗体
US20040086979A1 (en) Humanized rabbit antibodies
Kim et al. Generation, diversity determination, and application to antibody selection of a human naïve fab library
US20210079066A1 (en) Radically diverse human antibody library
TW202229328A (zh) 抗原特異性抗體之鑑定及產生
HK1192265B (en) Identifying affinity-matured human antibodies
HK1192265A (en) Identifying affinity-matured human antibodies

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: XBIOTECH INC.

Free format text: FORMER NAME(S): XBIOTECH, INC.